Klco, Jeffery M. http://orcid.org/0000-0003-2961-6960
Mullighan, Charles G. http://orcid.org/0000-0002-1871-1850
Article History
Accepted: 28 October 2020
First Online: 16 December 2020
Competing interests
: C.G.M. has received research funding from Loxo Oncology, Pfizer and AbbVie; has received speaking and travel fees from Amgen; holds stock in Amgen; and has been compensated for advisory board participation for Illumina. J.M.K. declares no competing interests.